BGM
KMTS

Burkehill Global Management’s Kestra Medical Technologies KMTS Stock Holding History

Burkehill Global Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Sell
25,000
-25,000
-50% -$523K 0.02% 162
2026
Q1 		$997K Hold
50,000
– – 0.05% 161
2025
Q4 		$1.33M Buy
+50,000
New +$1.29M 0.09% 137

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Burkehill Global Management's KMTS Position: Q2 2026 in Review

Burkehill Global Management reduced its Kestra Medical Technologies (KMTS) stake by 50% in Q2 2026, selling an estimated $523K and leaving 25,000 shares worth $636K. The position accounts for 0.02% of the portfolio, ranked #162.

Burkehill Global Management first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.33M in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Burkehill Global Management held 25,000 shares of Kestra Medical Technologies worth $636K as of Q2 2026.
  • Burkehill Global Management sold 25,000 Kestra Medical Technologies shares in Q2 2026, an estimated $523K.
  • Kestra Medical Technologies made up 0.02% of Burkehill Global Management's portfolio in Q2 2026, its #162 holding.
  • Burkehill Global Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • Burkehill Global Management's Kestra Medical Technologies position peaked at $1.33M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.